Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Albania | English
Albania | Shqip
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Albania | English
Albania | Shqip
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      Team meeting
      About

      Every day, we work to reimagine medicine to improve and extend people’s lives. Learn about us and our story.

      • Novartis in the US 
      • Our US Leadership 
      • People and culture 
      • Products 
      • Therapeutic areas 
        • Oncology 
        • Cardiovascular, Renal and Metabolic Disease 
        • Immunology 
      • Inclusion and belonging 
      • Manufacturing 
      • Partnerships 
      • Contact us 
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic hives (chronic urticaria) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
        • Breast Cancer 
        • Sjögren's Disease 
      • Participating in clinical trials 
      • Adverse event reporting 
      • Patient resources 
      Patient smiling at doctor image
      Patients and caregivers

      Visit resources tailored for our patient communities and their caregivers, including information around patient assistance, disease information and related resources.

    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • External funding 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray
      Healthcare professionals

      Visit our resource hub for information around clinical trials, our products and innovation pipeline.

    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Novartis in Society Integrated Report 
        • Novartis US Foundation 
        • People and communities 
        • Beacon of hope 
      • Environmental sustainability 
      Family and friends party at home
      ESG

      Learn about our commitment to making a positive impact on society through innovative medicine access, sustainability, and governance.

    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting
      News

      Check out our media hub for the latest news, stories, and updates from across our business.

    • Careers 
      • Career search 
      • Early career 
      • Employee benefits 
      • Inclusion and belonging  
      Colleagues laughing
      Careers

      Check out what careers are available at Novartis in the U.S. and learn about our people and culture.

Global Search Navigation
  • All
  • Site Pages
  • Media Releases
  • Featured News
  • Stories
Sort by
Hide Filters
Showing 79 results
  • State laws

  • California: NPC Declaration of Compliance

  • CA Health and Safety Code §119402

  • Annual Description of Comprehensive Compliance Program

  • Novartis US Leadership Team

  • Novartis US privacy policy center

  • Radioligand Therapy Production in Denton, TX

  • Biomedical Research organization in Cambridge, MA

  • Biomedical Research center in San Diego, CA

  • Cell Therapy Production in Morris Plains, NJ

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • › Next page

Related News & Media

Novartis scientist talks to woman on the street.
Word on the Street: What is cell and gene therapy?

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2026 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Cookie Settings
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only